OneSource Specialty Pharma Ltd (ONESOURCE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039523,
    "name": "OneSource Speci.",
    "stock_name": "OneSource Speci.",
    "full_name": "OneSource Specialty Pharma Ltd",
    "name_url": "stocks-analysis/onesource-speci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,195.00",
    "chg": 29.3,
    "chgp": "2.51%",
    "dir": 1,
    "prev_price": "1,165.70",
    "mcapval": "13,578.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544292,
    "symbol": "ONESOURCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE013P01021",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "4.0 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/onesource-speci-10039523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is OneSource Speci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onesource-speci-fallingrising-3722373",
        "imagepath": "",
        "date": "2025-11-22 01:38:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>The stock has been under pressure over the past week, registering a decline of 6.07%, in stark contrast to the Sensex, which gained 0.79% during the same period. Over the last month, the disparity widened further, with OneSource Specialty Pharma falling 11.84% while the Sensex rose by 0.95%. This divergence highlights the stock’s relative weakness amid a generally positive market environment. Year-to-date and longer-term returns for the stock are not available, but the Sensex’s gains of 9.08% YTD and 10.47% over one year provide a benchmark for comparison, underscoring the stock’s lagging performance.</p>\n<p><strong>Technical Indicators and Trading Activity</strong></p>\n<p>On the day of 21-Nov, the stock’s intraday low touched ₹1,59..."
      },
      {
        "title": "How has been the historical performance of OneSource Speci.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-onesource-speci-3695893",
        "imagepath": "",
        "date": "2025-11-13 00:44:25",
        "description": "Answer:\nThe historical performance of OneSource Speci. shows significant fluctuations in key financial metrics over the past four years, particularly from March 2022 to March 2025.\n\nBreakdown:\nOneSource Speci. experienced a dramatic increase in net sales, rising from 128.18 Cr in March 2022 to 1,444.85 Cr in March 2025. This surge in total operating income followed a similar trend, moving from 171.92 Cr in March 2024 to 1,444.85 Cr in March 2025. However, the company's total expenditure also escalated, reaching 978.34 Cr in March 2025, up from 260.16 Cr in March 2024. Despite the growth in revenue, the operating profit (PBDIT) improved to 483.98 Cr in March 2025 from a loss of 84.01 Cr in March 2024. Nevertheless, the company reported a profit before tax of -67.07 Cr in March 2025, an improvement from -365.70 Cr in March 2024. The profit after tax also showed a slight recovery, with a loss of -17.28 Cr in M..."
      },
      {
        "title": "Why is OneSource Speci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onesource-speci-fallingrising-3691458",
        "imagepath": "",
        "date": "2025-11-12 00:28:17",
        "description": "As of 11-Nov, OneSource Specialty Pharma Ltd is experiencing a decline in its stock price, currently at Rs 1,740.00, which reflects a decrease of Rs 50.9 or 2.84%. The stock opened with a gain of 2.17% today but subsequently fell, reaching an intraday low of Rs 1,737.65, indicating volatility within the trading session. The stock has underperformed its sector by 2.71% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 59.45% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, OneSource Specialty Pharma Ltd's performance over the past week shows a decline of 4.70%, while the benchmark Sensex has increased by 0...."
      }
    ],
    "total": 180,
    "sid": "10039523",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/onesource-specialty-pharma-10039523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "30-Jan-2026",
      "details": "Transcript of Earnings Call pertaining to unaudited Financial Results of the Company for the quarter ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "28-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Tenshi Pharmaceuticals Pvt Ltd & PACs",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations 2011 And Regulation 7(2) Of SEBI (PIT) Regulations 2015",
      "datetime": "28-Jan-2026",
      "details": "Disclosure under Regulation 29(2) of SEBI (SAST) Regulations 2011 and Regulation 7(2) of SEBI (PIT) Regulations 2015. Promoter entity (Tenshi Pharmaceuticals Private Limited) has purchased 200000 equity shares of the Company from the market on January 282026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is OneSource Speci. falling/rising?

2025-11-22 01:38:49

Recent Price Movement and Market Comparison The stock has been under pressure over the past week, registering a decline of 6.07%, in stark contrast to the Sensex, which gained 0.79% during the same period. Over the last month, the disparity widened further, with OneSource Specialty Pharma falling 11.84% while the Sensex rose by 0.95%. This divergence highlights the stock’s relative weakness amid a generally positive market environment. Year-to-date and longer-term returns for the stock are not available, but the Sensex’s gains of 9.08% YTD and 10.47% over one year provide a benchmark for comparison, underscoring the stock’s lagging performance. Technical Indicators and Trading Activity On the day of 21-Nov, the stock’s intraday low touched ₹1,59...

How has been the historical performance of OneSource Speci.?

2025-11-13 00:44:25

Answer: The historical performance of OneSource Speci. shows significant fluctuations in key financial metrics over the past four years, particularly from March 2022 to March 2025. Breakdown: OneSource Speci. experienced a dramatic increase in net sales, rising from 128.18 Cr in March 2022 to 1,444.85 Cr in March 2025. This surge in total operating income followed a similar trend, moving from 171.92 Cr in March 2024 to 1,444.85 Cr in March 2025. However, the company's total expenditure also escalated, reaching 978.34 Cr in March 2025, up from 260.16 Cr in March 2024. Despite the growth in revenue, the operating profit (PBDIT) improved to 483.98 Cr in March 2025 from a loss of 84.01 Cr in March 2024. Nevertheless, the company reported a profit before tax of -67.07 Cr in March 2025, an improvement from -365.70 Cr in March 2024. The profit after tax also showed a slight recovery, with a loss of -17.28 Cr in M...

Why is OneSource Speci. falling/rising?

2025-11-12 00:28:17

As of 11-Nov, OneSource Specialty Pharma Ltd is experiencing a decline in its stock price, currently at Rs 1,740.00, which reflects a decrease of Rs 50.9 or 2.84%. The stock opened with a gain of 2.17% today but subsequently fell, reaching an intraday low of Rs 1,737.65, indicating volatility within the trading session. The stock has underperformed its sector by 2.71% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 59.45% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, OneSource Specialty Pharma Ltd's performance over the past week shows a decline of 4.70%, while the benchmark Sensex has increased by 0....

View All News